Breast Imaging Technologies Market Insights on Market Challenges and New Trends
The Breast Imaging Technologies Market is expected to generate revenue of $4,502 million by 2022, with a CAGR of 8.4% over 2016-2222. North America and Europe together account for three quarters of the market share in 2015. The breast imaging technology is expected to continue its lead throughout the forecast period.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/5056
The key players profiled in this report include Dilon Technologies, Inc., FUJIFILM Holdings Corporation, Gamma Medica, Inc., General Electric Company, Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Siemens AG, Sonocin, Inc., and Toshiba Corporation.
Ionizing breast imaging technologies market accounted for major share of the global market in 2015, owing to their ability to detect breast cancer in early stages, thus increasing the chances of survival. Moreover, advancements in breast imaging tools facilitate faster interpretation of breast tissue and generate less false positive results as compared to MRI, which further accelerates the market growth. Non-ionizing imaging technologies are projected to grow with the highest CAGR, due to the introduction of better imaging modalities such as automated whole breast ultrasound system (ABUS). In addition, unlike ionizing breast imaging technologies, these techniques use infrared radiations, reducing the risk of developing radiation-induced cancer, which is thus anticipated to witness an increased demand in future.
Key findings of the Breast Imaging Technologies Market:
The ionizing breast imaging segment accounted for almost two-thirds of the total market in 2015, while non-ionizing breast imaging technologies is expected to be the fastest growing segment, recording a CAGR of 9.2% during the forecast period.
Full-field digital mammography system accounted for more than three-fourths of the total ionizing breast imaging technologies market in 2015.
3D breast tomosynthesis segment is expected to grow with the highest CAGR of 9.9%.
Among non-ionizing breast imaging technologies, breast MRI accounted for nearly two-fifths of the total market share in 2015. On the other hand, breast ultrasound is poised to grow at a faster rate at a CAGR of 9.9%.
Asia-Pacific is expected to expand at the highest CAGR of 9.5%.
North America was the highest revenue contributor to the global revenue in 2015 and is expected to maintain this trend throughout the forecast period. This is due to the rise in incidence of breast cancer, growth in awareness among patients regarding better breast imaging modalities, and availability of advanced healthcare facilities.